.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,241,065

« Back to Dashboard
Patent 7,241,065 protects CHLORAPREP WITH TINT and is included in one NDA.

This patent has eight patent family members in seven countries.

Summary for Patent: 7,241,065

Title:Applicator for coloring antiseptic
Abstract:An applicator usable to color antiseptics is provided. In one embodiment of the present invention, the applicator includes a flexible hollow body containing antiseptic to be applied. The applicator also has a porous element containing colorant positioned such that the antiseptic flows through the porous element containing colorant. Colorant is transferred to the antiseptic as it flows through the porous element. The resulting colored solution may be applied to the desired surface.
Inventor(s): Tufts; Scott A. (El Paso, TX), Flores; Jesus (El Paso, TX), Buzman; Manuel (El Paso, TX)
Assignee: Enturia, Inc. (Leawood, KS)
Application Number:11/254,318
Patent Claim Types:
see list of patent claims
Delivery;
Patent Metrics:
Source: PatentQuant.com
Field: Other consumer goods
Back Citations: 2nd percentile
Forward Citations: 0th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Becton Dickinson Co
CHLORAPREP WITH TINT
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-002May 3, 2005OTCYes7,241,065► subscribeY
Becton Dickinson Co
CHLORAPREP WITH TINT
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-005Apr 3, 2006OTCYes7,241,065► subscribeY
Becton Dickinson Co
CHLORAPREP WITH TINT
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-007Oct 10, 2006OTCYes7,241,065► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 7,241,065

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,422,388Applicator for coloring antiseptic► subscribe
6,729,786 Liquid applicator for coloring a liquid► subscribe
6,991,393Liquid applicator for coloring a liquid► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,241,065

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2004220817► subscribe
BrazilPI0408318► subscribe
Canada2519176► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc